Dr Anne-Laure Puaux

Dr Anne-Laure Puaux



Anne-Laure Puaux standing in a light corridor



MBA IE Business School Madrid PhD Paris-Grignon National Agronomic Institute

Head, Biotechnology and Commercialisation

I lead the Commercialisation team in the Institute’s Business Development Office.

Working closely with the Legal and Licensing team, we manage business development projects which capture and translate intellectual property and ultimately create value for the Institute and society by broadening the impact of scientific outcomes to improve public health and deliver sustained economic benefits. 

Our team is responsible for identifying promising commercialisation opportunities within the Institute’s research portfolio, and designing and implementing optimal commercialisation strategies for chosen projects. This may involve:

  • Licensing our intellectual property
  • Collaborating with industry
  • Spinning off new companies or joint ventures

We are committed to accelerating the translation of research discoveries into benefits for patients, while helping grow the Australian biotech ecosystem and ensuring a fair financial return for the Institute.

Global experience

I am an experienced business development leader in the life sciences sector. I started my career as an immunologist, and have held postdoctoral roles in academic and staff scientist positions within research and development departments of biopharma companies.

Prior to joining the Institute, I worked in Europe, the US, and Asia. As part of the global vaccine business unit at GlaxoSmithKline, I led new opportunities evaluation, business cases, and collaborative research projects, as well as designing, negotiating and closing deals with academic research institutes and biotech companies.

The unifying goal of my career has been designing partnerships that create value and are mutually beneficial, with an emphasis on developing early-stage assets from discovery to clinical proof-of-concept stage.

Venetoclax timeline of discovery

Starting with a landmark discovery in 1988, follow the story of how Institute research has driven development of a breakthrough anti-cancer drug. 

Minister Greg Hunt speaking from a podium

A landmark deal from the partial sale of royalty rights in anti-cancer treatment venetoclax secures the Institute’s place for innovation in medical research.